Plasma sphingolipids: potential biomarkers for severe hepatic fibrosis in chronic hepatitis C.

The plasma profile of sphingolipids in hepatic fibrosis patients with chronic hepatitis C (CHC) is rarely considered at present. The association between plasma sphingolipids and severe fibrosis in CHC remains an obscure area of research. The aim of the present study was to assess the plasma profile of sphingolipids and to examine the association between plasma sphingolipids and severe fibrosis in CHC, in order to identify potential novel markers of severe fibrosis in CHC.

Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level.

Accurate estimation of hepatic necroinflammation caused by chronic hepatitis C (CHC) is crucial for prediction of prognosis and design of therapeutic strategy, which is particularly true for CHC patients with normal alanine aminotransferase (ALT) level. Recent studies have shown that sphingolipids have a close relationship with hepatitis C virus infection. The present study aimed to identify plasma sphingolipids related to hepatic necroinflammation.

[Synthesis, crystal structure and luminescent properties of a dysprosium coordinaation polymer based on pyridine-2, 6-dicarboxylic acid].

2-D layered Dy coordination polymer [Dy(PDA) (HPDA)I]n (1)(H2PDA = pyridine-2,6-dicarboxylic acid) with (4.8(2)) topological network was synthesized under hydrothermal conditions and was characterized by elemental analysis, IR spectrum, and single-crystal X-ray diffraction. X-ray diffraction analysis reveals that compound 1 is monoclinic, space group P2(1)/c.